Annual EBITDA:
-$373.62M-$1.55B(-131.73%)Summary
- As of today, BNTX annual EBITDA is -$373.62 million, with the most recent change of -$1.55 billion (-131.73%) on December 31, 2024.
- During the last 3 years, BNTX annual EBITDA has fallen by -$21.31 billion (-101.78%).
- BNTX annual EBITDA is now -101.78% below its all-time high of $20.93 billion, reached on December 31, 2021.
Performance
BNTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$394.96M-$7.00M(-1.80%)Summary
- As of today, BNTX quarterly EBITDA is -$394.96 million, with the most recent change of -$7.00 million (-1.80%) on June 30, 2025.
- Over the past year, BNTX quarterly EBITDA has increased by +$415.30 million (+51.26%).
- BNTX quarterly EBITDA is now -106.97% below its all-time high of $5.67 billion, reached on March 31, 2022.
Performance
BNTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$55.72M+$415.30M(+88.17%)Summary
- As of today, BNTX TTM EBITDA is -$55.72 million, with the most recent change of +$415.30 million (+88.17%) on June 30, 2025.
- Over the past year, BNTX TTM EBITDA has dropped by -$29.23 million (-110.37%).
- BNTX TTM EBITDA is now -100.26% below its all-time high of $21.35 billion, reached on March 31, 2022.
Performance
BNTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BNTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -131.7% | +51.3% | -110.4% |
| 3Y3 Years | -101.8% | -119.0% | -100.3% |
| 5Y5 Years | -123.1% | -341.6% | +86.9% |
BNTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -101.8% | at low | -112.1% | +51.3% | -100.4% | +88.2% |
| 5Y | 5-Year | -101.8% | at low | -107.0% | +51.3% | -100.3% | +88.2% |
| All-Time | All-Time | -101.8% | at low | -107.0% | +51.3% | -100.3% | +88.2% |
BNTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$394.96M(-1.8%) | -$55.72M(+88.2%) |
| Mar 2025 | - | -$387.96M(-178.4%) | -$471.01M(-18.7%) |
| Dec 2024 | -$373.62M(-131.7%) | $495.03M(+113.2%) | -$396.75M(-345.5%) |
| Sep 2024 | - | $232.17M(+128.7%) | -$89.05M(-236.2%) |
| Jun 2024 | - | -$810.25M(-158.3%) | -$26.49M(-107.1%) |
| Mar 2024 | - | -$313.69M(-139.1%) | $370.49M(-75.5%) |
| Dec 2023 | $1.18B(-92.7%) | $802.73M(+172.4%) | $1.51B(-62.1%) |
| Sep 2023 | - | $294.73M(+171.3%) | $3.98B(-35.6%) |
| Jun 2023 | - | -$413.28M(-150.1%) | $6.19B(-28.7%) |
| Mar 2023 | - | $824.97M(-74.8%) | $8.68B(-35.8%) |
| Dec 2022 | $16.10B(-23.1%) | $3.28B(+31.0%) | $13.53B(-12.9%) |
| Sep 2022 | - | $2.50B(+20.0%) | $15.53B(-16.3%) |
| Jun 2022 | - | $2.08B(-63.3%) | $18.56B(-13.0%) |
| Mar 2022 | - | $5.67B(+7.3%) | $21.35B(+20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $20.93B(+8159.2%) | $5.28B(-4.4%) | $17.67B(+39.7%) |
| Sep 2021 | - | $5.53B(+13.5%) | $12.65B(+83.6%) |
| Jun 2021 | - | $4.87B(+144.0%) | $6.89B(+256.2%) |
| Mar 2021 | - | $2.00B(+665.3%) | $1.94B(+1868.1%) |
| Dec 2020 | -$259.75M(-55.1%) | $260.76M(+212.5%) | -$109.44M(+74.2%) |
| Sep 2020 | - | -$231.78M(-159.2%) | -$423.89M(-96.6%) |
| Jun 2020 | - | -$89.43M(-82.5%) | -$215.56M(-26.8%) |
| Mar 2020 | - | -$49.00M(+8.7%) | -$169.98M(-7.2%) |
| Dec 2019 | -$167.49M(-288.5%) | -$53.69M(-129.0%) | -$158.55M(-64.0%) |
| Sep 2019 | - | -$23.45M(+46.5%) | -$96.67M(-4.9%) |
| Jun 2019 | - | -$43.85M(-16.7%) | -$92.18M(-90.7%) |
| Mar 2019 | - | -$37.57M(-558.5%) | -$48.33M(-349.0%) |
| Dec 2018 | -$43.12M(+27.7%) | $8.19M(+143.2%) | -$10.76M(+43.2%) |
| Sep 2018 | - | -$18.96M | -$18.96M |
| Dec 2017 | -$59.61M | - | - |
FAQ
- What is BioNTech SE annual EBITDA?
- What is the all-time high annual EBITDA for BioNTech SE?
- What is BioNTech SE annual EBITDA year-on-year change?
- What is BioNTech SE quarterly EBITDA?
- What is the all-time high quarterly EBITDA for BioNTech SE?
- What is BioNTech SE quarterly EBITDA year-on-year change?
- What is BioNTech SE TTM EBITDA?
- What is the all-time high TTM EBITDA for BioNTech SE?
- What is BioNTech SE TTM EBITDA year-on-year change?
What is BioNTech SE annual EBITDA?
The current annual EBITDA of BNTX is -$373.62M
What is the all-time high annual EBITDA for BioNTech SE?
BioNTech SE all-time high annual EBITDA is $20.93B
What is BioNTech SE annual EBITDA year-on-year change?
Over the past year, BNTX annual EBITDA has changed by -$1.55B (-131.73%)
What is BioNTech SE quarterly EBITDA?
The current quarterly EBITDA of BNTX is -$394.96M
What is the all-time high quarterly EBITDA for BioNTech SE?
BioNTech SE all-time high quarterly EBITDA is $5.67B
What is BioNTech SE quarterly EBITDA year-on-year change?
Over the past year, BNTX quarterly EBITDA has changed by +$415.30M (+51.26%)
What is BioNTech SE TTM EBITDA?
The current TTM EBITDA of BNTX is -$55.72M
What is the all-time high TTM EBITDA for BioNTech SE?
BioNTech SE all-time high TTM EBITDA is $21.35B
What is BioNTech SE TTM EBITDA year-on-year change?
Over the past year, BNTX TTM EBITDA has changed by -$29.23M (-110.37%)